Wednesday, September 20, 2023
Excessive Caffeine and Stress as Causes of Tremors
SMA is a neurological disease that affects motor neurons.
SMA is a neurological disease that affects motor neurons, leading to muscle weakness and atrophy. When the disease begins to affect the respiratory muscles, it can result in life-threatening outcomes. Although a definitive cure is not yet possible, appropriate treatment can help halt the progression of the disease.
Spinal muscular atrophy (SMA) refers to a group of genetic disorders that lead to muscle atrophy. SMA occurs due to the loss of nerve cells located in the brainstem and spinal cord. This loss causes dysfunction in the muscles innervated by these nerves, resulting in muscle atrophy. Due to the atrophied—or, in simpler terms, weakened—muscles, SMA patients may struggle with movements such as walking, standing, controlling head movements, swallowing, and breathing.
Some types of SMA are present from birth, while others manifest later in life. SMA is known to affect approximately one in every 8,000-10,000 people.
SMA is a progressive disease that leads to increasingly severe symptoms over time. Although there is currently no cure for SMA, available treatments can slow or halt the disease's progression. These treatments may also alleviate symptoms and improve the patient’s quality of life.
SMA has several types, categorized by the age at which symptoms appear, the patient’s life expectancy, and quality of life. The types of SMA are:
The symptoms of SMA vary depending on the type of the disease and when it manifests.
Symptoms of SMA Type 1:
Symptoms of SMA Type 2 are generally milder than those of Type 1. They include:
SMA Type 3 patients can stand and walk independently, though they may lose these abilities over time. Additional symptoms include:
Symptoms of SMA Type 4:
SMA is caused by mutations in the SMN1 and SMN2 genes. These mutations lead to the inability of motor neurons in the spinal cord and brainstem to function properly.
Motor neurons are nerve cells responsible for controlling movement. The SMN1 and SMN2 genes are responsible for producing a protein essential for the function of motor neurons.
The SMN1 gene is primarily associated with the onset of SMA, while the SMN2 gene influences the severity and progression of the disease.
Genetic mutations that cause SMA are present in about 1 in every 40 to 60 people in the population. For a person to develop SMA, they must inherit mutated genes from both parents. However, even if both genes are inherited, the chance of developing the disease is 25%. Therefore, people with the genetic mutation can still live healthy lives.
SMA diagnosis often begins when families notice symptoms in their child. The doctor will carefully evaluate the child’s symptoms and take a detailed medical history of the child and family. Physical examination is crucial for diagnosis. If signs like muscle weakness or floppiness are detected, further tests may be required.
Blood tests, muscle biopsy, and electromyography (EMG) are some methods used in diagnosing SMA. EMG assesses muscle function and the nerve cells responsible for muscle movement.
If SMA is suspected during pregnancy, amniocentesis and chorionic villus sampling can confirm the diagnosis.
People with SMA may have an increased susceptibility to respiratory infections. Pneumonia, particularly affecting the lower respiratory tract, can cause severe complications in these patients. Symptoms of pneumonia include coughing, fever, shortness of breath, wheezing, nausea, and vomiting.
While SMA cannot be completely cured, some recently developed treatments can help halt the disease's progression. SMA is a progressively worsening condition, but treatment can help prevent further deterioration and preserve abilities like sitting and walking.
New medications are available that focus on gene therapy to treat the disease. Alongside drug treatments, interventions to help SMA patients remain active can improve their quality of life. Breathing exercises, nutritional management, and activities to stretch and strengthen muscles can be beneficial. Assistive devices like ventilators and powered wheelchairs also support a better quality of life.
It is important for patients and their caregivers to be informed about SMA and to have supportive family and friends to improve adherence to treatment. SMA patients should seek care at a well-equipped medical center for both medical and supportive therapies.
Last Updated Date: 07 December 2021
Publication Date: 07 December 2021
Neurology Department
Neurology Department
Featured Cancer Articles